Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036)

NCT01300455 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Apnea

Interventions

DRUG: Suvorexant
DRUG: Matching Placebo

Sponsor

Merck Sharp & Dohme LLC